Expression of CCL20 and Its Corresponding Receptor CCR6 Is Enhanced in Active Inflammatory Bowel Disease, and TLR3 Mediates CCL20 Expression in Colonic Epithelial Cells

BACKGROUND: The chemokine CCL20 and its receptor CCR6 are putative drug targets in inflammatory bowel disease, and CCL20 is a novel IBD predilection gene. Previous findings on the CCL20 response in these diseases are divergent. This study was undertaken to examine CCL20 and CCR6 during active and in...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:PLoS One
Asıl Yazarlar: Skovdahl, Helene Kolstad, Granlund, Atle van Beelen, Østvik, Ann Elisabet, Bruland, Torunn, Bakke, Ingunn, Torp, Sverre Helge, Damås, Jan Kristian, Sandvik, Arne Kristian
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2015
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4633243/
https://ncbi.nlm.nih.gov/pubmed/26536229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0141710
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller